quinazolines has been researched along with Cervical Tuberculous Lymphadenitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Amorim, JC; Arévalo, JMC | 1 |
1 other study(ies) available for quinazolines and Cervical Tuberculous Lymphadenitis
Article | Year |
---|---|
Virtual screening, optimization and molecular dynamics analyses highlighting a pyrrolo[1,2-a]quinazoline derivative as a potential inhibitor of DNA gyrase B of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; DNA Gyrase; Humans; Molecular Dynamics Simulation; Mycobacterium tuberculosis; Quinazolines; Topoisomerase II Inhibitors; Tuberculosis, Lymph Node | 2022 |